Biogen and Eisai revive plans for Alzheimer’s drug, surprising market Reuters Oct 23, 2019 The field of experimental Alzheimer’s treatments is littered with high-profile failures, with many major drugmakers abandoning the…
Glenmark Pharmaceuticals receives tentative ANDA approval for Rufinamide tablets USP Usha Sharma May 21, 2015 Under the terms of a settlement agreement between Glenmark and Eisai, Glenmark will be permitted to market this product in the US…
